MSKCC 9th Annual MSK Symposium on Lymphoma — On Demand 2025

This annual symposium provides a comprehensive overview of the latest advancements in the evolving field of lymphoma. The 9th edition of the program, originally recorded live from April 25–26, 2025, brought together leading national and international experts to present cutting-edge discoveries in lymphoma biology, state-of-the-art diagnostic techniques, and innovative treatment strategies. The program highlights the clinical management of common lymphoma subtypes while also exploring groundbreaking drug developments, advances in lymphoma biology and pathology, and how these discoveries are being translated into meaningful improvements in patient care. To view the full agenda and list of presentations, please refer to the brochure from the live symposium.

Session Topics

• Current Challenges in the Management of Follicular Lymphoma
• Advances in Therapeutic Strategies for Mantle Cell Lymphoma
• Hodgkin Lymphoma
• The Dark Side of B-Cells
• Improving Outcomes for Patients with T-Cell Lymphoma
• Aggressive B-Cell Lymphoma: Addressing Remaining Gaps on the Path to a Definitive Cure
• CAR T-Cell Therapies in Large B-Cell Lymphoma: Who, When, and How?

Keynote Presentations

• Chris Flowers, MD, MPH (MD Anderson Cancer Center): Epidemiology and Outcomes in Lymphoma
• Margaret Shipp, MD (Dana-Farber Cancer Institute): Biology of Hodgkin Lymphoma
• David Maloney, MD, PhD (Fred Hutchinson Cancer Research Center): Lessons and Challenges

Target Audience

This program is designed for internists, oncologists, hematologists, medical and radiation oncologists, hematopathologists, scientists, and medical trainees involved in the diagnosis, treatment, and research of lymphoma.

1. Describe recent advances in lymphoma classification
2. Discuss first line treatment options in most frequent lymphoma entities
3. Describe new agents mode of actions, efficacy, side effects
4. Discuss options and recommendations for patients in the relapse refractory setting
5. Provide adequate information to help shared decision with patients regarding their treatment